GSK to acquire Aiolos Bio to expand respiratory treatment portfolio

GSK plc (LSE/NYSE: GSK) and Aiolos Bio, Inc. (Aiolos) have announced a significant agreement, where GSK will acquire Aiolos, a clinical-stage biopharmaceutical company focusing on ... Read More